ReCKordTM Cyberknife® Registry (RSSearch® Registry)
IRB #: 11-014
Principal Investigator: Frank Kimsey, M.D.
Co-Investigator: Jeffrey Gefter, M.D.
CyberKnife Registry is not a drug clinical trial or study, but patients must give consent.
Purpose: The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (stereotactic radiosurgery/stereotactic body radiotherapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases (This study was formally called ReCKord and included the Cyberknife only).
Drugs possibly given:
Please view the complete trial information at: http://www.clinicaltrials.gov/ct2/show/NCT01563549?term=reckord&rank=1